SEC Form 4 · accession 0001140361-16-068754
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandy Macrae
Officer — President and CEO
Period of report
Jun 3, 2016
Accepted (ET)
Jun 6, 2016 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $7.07 | Jun 3, 2016 | A | 700,000 | A | — | Jun 2, 2026 | Common Stock | 700,000 | 700,000 | D |
Explanation of responses
- F1One-quarter (1/4) of the shares issuable upon exercise of the stock option (the "Option Shares") will vest upon completion of one (1) year of service by the Reporting Person from June 1, 2016 and the remainder will vest in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains a full-time employee through each such vesting date.